Image

Global Melanoma Therapeutics Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Melanoma Therapeutics Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Melanoma Therapeutics Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3.45 USD Billion
Diagram Market Size (Forecast Year) USD 11.55 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Melanoma Therapeutics Market, By Type (Superficial Spreading Melanoma, Nodular Melanoma, Lentigo Maligna Melanoma, Acral Lentiginous Melanoma, Amelanotic Melanoma, Others), Stages (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4, Others), Therapy (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, Others), Drug Type (Branded, Generic), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Melanoma Therapeutics Market

Melanoma Therapeutics Market Analysis and Size

As per the records of WHO, around 132,000 cases of skin cancer occur each year. Furthermore, a 10% decrease in ozone levels is projected to lead to an increase of 4,500 skin cancer cases globally. The incidence of skin allergies, melanoma, and other skin cancers in highly developing countries is high, that serves as an opportunity for drug companies to gain a larger share in these regions. Genes and UV radiations are majorly responsible for causing melanoma.

Data Bridge Market Research analyses a growth rate in the melanoma therapeutics market in the forecast period 2023-2030. The expected CAGR of melanoma therapeutics market is tend to be around 16.30% in the mentioned forecast period. The market was valued at USD 3.45 billion in 2022, and it would grow upto USD 11.55 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Melanoma Therapeutics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Superficial Spreading Melanoma, Nodular Melanoma, Lentigo Maligna Melanoma, Acral Lentiginous Melanoma, Amelanotic Melanoma, Others), Stages (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4, Others), Therapy (Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, Others), Drug Type (Branded, Generic), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Sanofi S.A. (France), Bayer AG (Germany), Lilly (U.S.), Merck & Co., Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), Bausch Health Companies Inc. (Canada), F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Switzerland), Genentech, Inc (U.S.), AstraZeneca (U.K.), DAIICHI SANKYO COMPANY, LIMITED (Japan), AB Science (France), AgonOX (U.S.), Eisai Co., Ltd (Japan), Pfizer, Inc.(U.S.)

Market Opportunities

  • Growing Regulatory Approvals By Authorizations
  • Development of new Biologics

Market Definition

Melanoma is the most hazardous type of skin cancer that develops in the melanocytes cells which produce melanin. Melanoma can also produce in the eyes and most rarely inside the body such as nose and throat. There are various risk factors for melanoma, including overexposure to the sun, a family history of melanoma, and having fair skin, among others. Melanoma is considered to be the deadliest of these three types of skin cancer.

Global Melanoma Therapeutics Market

Drivers

  • Increasing Demand of Radiation Therapy

The radiation therapy is projected to show steady growth during the forecast period due to the growing number of advanced melanoma cases and the increasing use of radiation as an adjuvant therapy post-surgery. Radiation therapy is often used as a primary treatment. It is only administered to stage 4 patients who cannot be treated with surgery.

  • Increase in Skin Cancer

According to records of WHO, about 132,000 cases of skin cancer occur each year. Additionally, a 10% reduction in ozone levels is projected to lead to an increase of 4,500 skin cancer cases worldwide. The incidence of skin allergies, melanoma, and other skin cancers in developing countries is more, that serves as an opportunity for many drug companies to gain a greater share in these regions. This is estimated to increase the demand for these drugs during the forecast period.

Opportunities

  • Growing Regulatory Approvals By Authorizations

The high emphasis and increasing investment in highly developing efficient treatment options are most likely to significantly impact the market growth. Treatment recommendations depend on several factors, and the increasing number of regulatory approvals has considerably impacted the market growth. For instance, in 2021, Binimetinib, Braftovi, Aldesleukin, Cobimetinib Fumarate, Dabrafenib Mesylate, Cotellic were some of the approved drugs that are used for the treatment of cancer by FDA. The significance of major key players on introducing several innovative treatment options and drugs will support the market growth in the upcoming years.   

  • Development of new Biologics

The major market players in the U.S., Europe, and Asia Pacific are focusing on developing several new biologics for the treatment of melanoma. For instance, in March 2017, Take a Novel Challenge for Drug Discovery (TaNeDS) was introduced by Daiichi Sankyo Company Limited, a collaborative project aimed at facilitating new drug development through various collaborations. In addition to this, it has a strategic research partnership with AgonOX, Inc. to explore innovative immunotherapy treatments for the market.

 Restraints/Challenges

  • Unavailability of Appropriate Treatments

To treat many different types of cancers, there are times when all treatments are not available, particularly in underdeveloped countries. Severe patients need to be treated with many advanced techniques, but these are sometimes unavailable in the hospitals and clinics. Therefore, it impedes the market growth.

  • Increasing Rate of Patent Expiration Drugs

There are several drugs that lose expiry and it takes much time to get back the patent. Branded drugs are anticipated to lose their market share during the forecast period because of the patent expiration of notable brands such as Yervoy and Imlygic. Imlygic is projected to lose its patent protection in 2021, which will result in reduced revenue for Amgen, Inc. Likewise, Yervoy is estimated to lose its patent exclusivity in the U.S. in 2022 and Europe in 2020.

This melanoma therapeutics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the melanoma therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Melanoma Therapeutics Market

The pandemic has considerably affected various diagnostic methods due to numerous restrictions and risk exposure of comorbidity patients. A drastic reduction in skin biopsies was seen early in the COVID-19 pandemic, which unreasonably affected the elderly, females, and certain geographic regions. Though, government organizations have made efforts to contain the situation in the post-pandemic era.

Recent Development:

In 2020, AstraZeneca and Merck & Co. got FDA approval of the drug selumetinib to treat neurofibromatosis type 1, or NF1, a rare and characteristically inherited disease which causes tumors to grow inside nerve sheaths. Additionally, Merck joined AstraZeneca in developing and commercializing Koselugo as part of a deal that included the ovarian cancer drug Lynparza.

Global Melanoma Therapeutics Market Scope

The melanoma therapeutics market is segmented on the basis of type, stages, chemotherapy, drug type, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Superficial Spreading Melanoma
  • Nodular Melanoma
  • Lentigo Maligna Melanoma
  • Acral Lentiginous Melanoma
  • Amelanotic Melanoma
  • Others

Stages

  • Stage 0
  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4
  • Others

Chemotherapy

  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Immunotherapy
  • Others

Drug Type

  • Branded
  • Generic

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Melanoma Therapeutics Market Regional Analysis/Insights

The melanoma therapeutics market is analyzed and market size insights and trends are provided by ype, stages, chemotherapy, drug type, distribution channel and end-user as referenced above.

The major countries covered in the melanoma therapeutics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for melanoma therapeutics market throughout the forecasted period due to the constant rise in skin cancer and increased demand for cost-efficient therapeutics.

North America dominates the market due to the presence of high healthcare expenditure and favorable reimbursement policies for treatment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Melanoma Therapeutics Market Share Analysis

The melanoma therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to melanoma therapeutics market.

Key players operating in the melanoma therapeutics market include:

  • Johnson & Johnson Private Limited (U.S.)
  • Mylan N.V. (U.S.)
  • Sun Pharmaceutical Industries Limited (India)
  • Sanofi S.A. ( France)
  • Bayer AG (Germany)
  • Lilly (U.S.)
  • Merck & Co., Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • AbbVie Inc. (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Amgen Inc. (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Novartis AG (Switzerland)
  • Genentech, Inc (U.S.)
  • AstraZeneca (U.K.)
  • DAIICHI SANKYO COMPANY, LIMITED (Japan)
  • AB Science (France)
  • AgonOX (U.S.)
  • Eisai Co., Ltd (Japan)
  • Pfizer, Inc.(U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Melanoma Therapeutics Market is projected to grow at a CAGR of 16.30% during the forecast period by 2030.
The future market value of the Melanoma Therapeutics Market is expected to reach USD 11.55 billion by 2030.
The major players in the Melanoma Therapeutics Market are Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Sanofi S.A. (France), Bayer AG (Germany), Lilly (U.S.), Merck & Co., Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), etc.
The countries covered in the Melanoma Therapeutics Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials